TriNetX is the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence. TriNetX combines real time access to longitudinal clinical data with state-of-the-art analytics to answer complex research questions at the speed of thought. The TriNetX platform is HIPAA and GDPR compliant.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/13/19 | $40,000,000 | Series D |
Deerfield Management Company, L.P. F2 Capital ITOCHU Corporation ITOCHU Technology Ventures Merck Global Health Innovation Fund  Mitsui & Co MPM Capital | undisclosed |
